| Market Size in 2024 | Market Forecast in 2034 | CAGR (in %) | Base Year |
|---|---|---|---|
| USD 3.19 Billion | USD 6.12 Billion | 6.73% | 2024 |
FrequentlyAsked Questions
An inflammation-related disorder that commonly affects the corners of the mouth or oral commissures is called angular cheilitis. It is also referred to as perleche (perlèche), cheilosis, angular stomatitis, and rhagades. At the angles of the mouth, where two different kinds of skin lining converge and serve as a hinge, angular cheilitis develops.
The global angular cheilitis treatment market is expected to grow due to increasing fungal and bacterial infections, rising prevalence of nutritional deficiencies, growing awareness of oral health, and advancements in dermatological treatments.
According to a study, the global angular cheilitis treatment market size was worth around USD 3.19 Billion in 2024 and is expected to reach USD 6.12 Billion by 2034.
The global angular cheilitis treatment market is expected to grow at a CAGR of 6.73% during the forecast period.
North America is expected to dominate the angular cheilitis treatment market over the forecast period.
Leading players in the global angular cheilitis treatment market include Novartis AG (Switzerland), Endo, Inc. (Ireland), Teva Pharmaceutical Industries Ltd. (Israel), Cipla (India), Dr. Reddy’s Laboratories Ltd. (India), Abbott (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Pfizer Inc., (U.S.), Zydus Group (India), Lupin (India), Bayer AG (Germany), Torrent Pharmaceuticals Ltd., (India), Cadila Pharmaceuticals. (India), Piramal Enterprises Ltd. (India), Lannett (U.S.), Aurobindo Pharma. (India), Hikma Pharmaceuticals PLC (U.K.), Alkem (India), Cosette Pharmaceuticals (U.K.), GSK Plc (U.K.), Amneal Pharmaceutical Inc. (U.S.), Mylan N.V. (U.S.), Sun Pharmaceutical Industries Ltd., (India), Perrigo Company plc (Ireland), and Akorn Operating Company LLC (India), among others.
The report explores crucial aspects of the angular cheilitis treatment market, including a detailed discussion of existing growth factors and restraints, while also examining future growth opportunities and challenges that impact the market.
HappyClients